Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT)
  2. Harrison, Jerry Joe E K; Tuske, Steve; Das, Kalyan; Ruiz, Francesc X; Bauman, Joseph D; Boyer,Paul; DeStefano, Jeffrey J; Hughes,Stephen; Arnold, Eddy
  3. Viruses. 2021, Aug; 13(8):
  1. 2.   Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling
  2. Valdeira, Ana S C; Ritt,Daniel; Morrison,Deborah; McMahon, James B; Gustafson, Kirk R; Salvador, Jorge A R
  3. Frontiers in chemistry. 2018, Sep 28; 6: 434.
  1. 3.   Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor
  2. Xiao, X. D.; Feng, Y.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2011, Jul; 411(2): 253-258.
  1. 4.   Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1 beta Activation and Severe Autoinflammation in Mice
  2. Chae, J. J.; Cho, Y. H.; Lee, G. S.; Cheng, J.; Liu, P. P.; Feigenbaum, L.; Katz, S. I.; Kastner, D. L.
  3. Immunity. 2011, May; 34(5): 755-768.
  1. 5.   A large human domain antibody library combining heavy and light chain CDR3 diversity
  2. Chen, W. Z.; Zhu, Z. Y.; Feng, Y.; Dimitrov, D. S.
  3. Molecular Immunology. 2010, Jan; 47(4): 912-921.
  1. 6.   Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1
  2. Zhang, M. Y.; Borges, A. R.; Ptak, R. G.; Wang, Y. P.; Dimitrov, A. S.; Alam, S. M.; Wieczorek, L.; Bouma, P.; Fouts, T.; Jiang, S. B.; Polonis, V. R.; Haynes, B. F.; Quinnan, G. V.; Montefiori, D. C.; Dimitrov, D. S.
  3. Mabs. 2010, May-Jun; 2(3): 266-274.
  1. 7.   Aprotease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
  2. Weldon, J. E.; Xiang, L. M.; Chertov, O.; Margulies, I.; Kreitman, R. J.; FitzGerald, D. J.; Pastan, I.
  3. Blood. 2009 113(16): 3792-3800.
  1. 8.   Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-I
  2. Giomarelli, B.; Washington, V. A.; Chisholm, M. M.; Quigley, L.; McMahon, J. B.; Mori, T.; McVicar, D. W.
  3. Thrombosis and Haemostasis. 2007, Jun; 97(6): 955-964.
  1. 9.   Intracellular restriction factors in mammalian cells - An ancient defense system finds a modern foe
  2. Baumann, J. G.
  3. Current HIV Research. 2006, Apr; 4(2): 141-168.
  1. 10.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 11.   Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. British Journal of Haematology. 2005, MAR; 128(5): 602-609.
  1. 12.   A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22(+) tumor cells
  2. Arndt, M. A. E.; Krauss, J.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. Journal of Immunotherapy. 2005, MAY-JUN; 28(3): 245-251.
  1. 13.   Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers
  2. Arndt, M. A. E.; Krauss, R.; Rybak, S. M.
  3. Febs Letters. 2004, DEC 17; 578(3): 257-261.
  1. 14.   Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh)
  2. Raafat, A.; Bargo, S.; Anver, M. R.; Callahan, R.
  3. Oncogene. 2004, DEC 16; 23(58): 9401-9407.
  1. 15.   Murine T cells potently restrict human immunodeficiency virus infection
  2. Baumann, J. G.; Unutmaz, D.; Miller, M. D.; Breun, S. K. J.; Grill, S. M.; Mirro, J.; Littman, D. R.; Rein, A.; KewalRamani, V. N.
  3. Journal of Virology. 2004, NOV; 78(22): 12537-12547.
  1. 16.   Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
  2. Zhang, M. Y.; Shu, Y. U.; Rudolph, D.; Prabakaran, P.; Labrijn, A. F.; Zwick, M. B.; Lal, R. B.; Dimitrov, D. S.
  3. Journal of Molecular Biology. 2004 335(1): 209-219.
  1. 17.   Impact of antibody framework residue V-H-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Zhu, Z.; Newton, D. L.; Vu, B. K.; Choudhry, V.; Darbha, R.; Ji, X.; Courtenay-Luck, N. S.; Deonarain, M. P.; Richards, J.; Rybak, S. M.
  3. British Journal of Cancer. 2004 90(9): 1863-1870.
  1. 18.   Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
  2. Krauss, J.; Arndt, M. A. E.; Martin, A. C. R.; Liu, H. T.; Rybak, S. M.
  3. Protein Engineering. 2003 16(10): 753-759.
  1. 19.   Generation of a highly stable, internalizing anti-CD22 single- chain Fv fragment for targeting non-Hodgkin's lymphoma
  2. Arndt, M. A. E.; Krauss, J.; Schwarzenbacher, R.; Vu, B. K.; Greene, S.; Rybak, S. M.
  3. International Journal of Cancer. 2003 107(5): 822-829.
  1. 20.   Recombinant antibodies for the diagnosis and treatment of cancer
  2. Krauss, J.
  3. Molecular Biotechnology. 2003 25(1): 1-17.
  1. 21.   Preparation of recombinant RNase single-chain antibody fusion proteins
  2. Newton, D. L.; Rybak, S. M.
  3. Molecular Biotechnology. 2002 20(1): 63-76.
  1. 22.   Diverting a protein from its cellular location by intracellular antibodies - The case of p21Ras
  2. Lener, M.; Horn, I. R.; Cardinale, A.; Messina, S.; Nielsen, U. B.; Rybak, S. M.; Hoogenboom, H. R.; Cattaneo, A.; Biocca, S.
  3. European Journal of Biochemistry. 2000 267(4): 1196-1205.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel